close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Hantavirus outbreak isn't another Covid pandemic – but experts say it's testing U.S. readiness
Tags Social issues Biotechnology Carnival Corp
From CNBC.com News
Inside India newsletter: Trump-Xi meeting could test India’s positioning as China counterweight
Tickers RH
Tags S&P Global Inc RH Franco/Nevada Corp
From CNBC.com News
Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
Tags Healthy Returns Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
Tags Markets Novo Nordisk A/S U/S/ Markets
From CNBC.com News
Asia's trillion-dollar titans are powering — and distorting — its fastest growing stock markets
Tags Taiwan Semiconductor Manufacturing Co Ltd iShares MSCI Taiwan ETF Asia News
From CNBC.com News
Global week ahead: Crude diplomacy casts shadow over Trump-Xi summit
Tags Economic events Commerzbank AG iShares MSCI South Korea ETF
From CNBC.com News
CNBC Daily Open: Leadership challenge swirls around Starmer
Tags Market Outlook Walt Disney Co HSBC Holdings PLC
From CNBC.com News
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
Tags Biotech and Pharmaceuticals Healthy Returns Eli Lilly and Co
From CNBC.com News
CNBC Daily Open: Iran reviews 'one-page peace plan'
Tags Apple Inc Daily Open World Markets
From CNBC.com News
Inside India newsletter: Social media is reshaping the world's fastest-growing market for global brands
Tickers RH
Tags S&P Global Inc Franco/Nevada Corp RH
From CNBC.com News
Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
Tags Biotech and Pharmaceuticals Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Wegovy sales smash forecasts after pill launch as Novo Nordisk hikes guidance
Tags Biotechnology Breaking News: Europe Europe Markets
From CNBC.com News
European stocks set to rise as oil prices fall after Trump signals Iran war de-escalation
Tags Foreign policy World Economy Flutter Entertainment PLC
From CNBC.com News
CNBC Daily Open: Kospi bull run rolls on
Tags Asia Markets Microsoft Corp Strategy Inc
From CNBC.com News
Iran tensions, Palantir earnings, Musk's SEC settlement and more in Morning Squawk
Tags eBay Inc Amazon/com Inc Procter & Gamble Co
From CNBC.com News
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance
Tags Biotech and Pharmaceuticals Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds
Tags Business Business News Pharmaceuticals
From CNBC.com News
CNBC Daily Open: As Gulf fatigue sets in, earnings take center stage
Tags Foreign policy eBay Inc AP Moeller / Maersk A/S
From CNBC.com News
Global week ahead: Is 'Sell in May' just a myth?
Tags iShares Core U/S/ Aggregate Bond ETF Deutsche Bank AG Diageo PLC
From CNBC.com News
Weight loss and hair loss: The growing hair treatment market from GLP-1s
Tags Accenture PLC e/commerce Retail industry
From CNBC.com News
Apple earnings, DHS shutdown, 'Ozempic breath' and more in Morning Squawk
Tags Microsoft Corp Business Business News
From CNBC.com News
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Tags Novo Nordisk A/S Eli Lilly and Co Health & Science
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tags Eli Lilly and Co Novo Nordisk A/S Breaking News: Business
From CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Food and Beverage Hotels and Leisure Travel
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags Health care industry Business News Business
From CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
Tags Eli Lilly and Co Novo Nordisk A/S Breaking News: Business
From CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Tags Health & Science Breaking News: Business Novo Nordisk A/S
From CNBC.com News
Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk
Tags Intel Corp Economy Markets
From CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Tags US: News Companies Pharmaceuticals
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
Tags Economy Markets Eli Lilly and Co
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.